Literature DB >> 19116307

The first deletion mutation in the TSP1-6 repeat domain of ADAMTS13 in a family with inherited thrombotic thrombocytopenic purpura.

Roberta Palla1, Silvia Lavoretano, Rossana Lombardi, Isabella Garagiola, Mehran Karimi, Abdolreza Afrasiabi, Mani Ramzi, Raimondo De Cristofaro, Flora Peyvandi.   

Abstract

The inherited deficiency of ADAMTS13 is usually associated with severe forms of thrombotic thrombocytopenic purpura. Among the mutations identified in the ADAMTS13 gene, none have been described on the TSP1-6 repeat domain. We investigated an Iranian family with a history of chronic recurrent thrombotic thrombocytopenic purpura, severe ADAMTS13 deficiency and a heterogeneous pattern of clinical symptoms among affected members. Genetic analysis revealed a homozygous deletion of nucleotides 2930-2935 (GTGCCC) in exon 23 of ADAMTS13, leading to the replacement of Cys977 by a Trp and the deletion of Ala978 and Arg979 in the TSP1-6 repeat domain. To explore the mechanism of ADAMTS13 deficiency, in vitro expression studies were performed. Western blotting, pulse-chase labeling and immunofluorescence studies demonstrated a secretion pathway defect of the mutant protein, with no intracellular accumulation. This finding is consistent with the severe ADAMTS13 deficiency but does not explain the heterogeneous clinical picture of the 3 siblings carrying the same mutation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19116307      PMCID: PMC2635406          DOI: 10.3324/haematol.13524

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  24 in total

1.  Inherited and de novo mutations of ADAMTS13 in a patient with Upshaw-Schulman syndrome.

Authors:  K Kokame; Y Aoyama; M Matsumoto; Y Fujimura; T Miyata
Journal:  J Thromb Haemost       Date:  2007-11-06       Impact factor: 5.824

Review 2.  Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease.

Authors:  M Furlan; B Lämmle
Journal:  Best Pract Res Clin Haematol       Date:  2001-06       Impact factor: 3.020

3.  Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura.

Authors:  G G Levy; W C Nichols; E C Lian; T Foroud; J N McClintick; B M McGee; A Y Yang; D R Siemieniak; K R Stark; R Gruppo; R Sarode; S B Shurin; V Chandrasekaran; S P Stabler; H Sabio; E E Bouhassira; J D Upshaw; D Ginsburg; H M Tsai
Journal:  Nature       Date:  2001-10-04       Impact factor: 49.962

4.  Ten candidate ADAMTS13 mutations in six French families with congenital thrombotic thrombocytopenic purpura (Upshaw-Schulman syndrome).

Authors:  A Veyradier; J-M Lavergne; A-S Ribba; B Obert; C Loirat; D Meyer; J-P Girma
Journal:  J Thromb Haemost       Date:  2004-03       Impact factor: 5.824

Review 5.  Genetic defects leading to hereditary thrombotic thrombocytopenic purpura.

Authors:  Koichi Kokame; Toshiyuki Miyata
Journal:  Semin Hematol       Date:  2004-01       Impact factor: 3.851

Review 6.  Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura.

Authors:  J Evan Sadler
Journal:  Blood       Date:  2008-07-01       Impact factor: 22.113

7.  Prevalence of the ADAMTS-13 missense mutation R1060W in late onset adult thrombotic thrombocytopenic purpura.

Authors:  R S Camilleri; H Cohen; I J Mackie; M Scully; R D Starke; J T B Crawley; D A Lane; S J Machin
Journal:  J Thromb Haemost       Date:  2007-11-20       Impact factor: 5.824

8.  ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission.

Authors:  Flora Peyvandi; Silvia Lavoretano; Roberta Palla; Hendrik B Feys; Karen Vanhoorelbeke; Tullia Battaglioli; Carla Valsecchi; Maria Teresa Canciani; Fabrizio Fabris; Samo Zver; Marienn Réti; Danijela Mikovic; Mehran Karimi; Gaetano Giuffrida; Luca Laurenti; Pier Mannuccio Mannucci
Journal:  Haematologica       Date:  2008-01-26       Impact factor: 9.941

9.  Molecular characterization of four ADAMTS13 mutations responsible for congenital thrombotic thrombocytopenic purpura (Upshaw-Schulman syndrome).

Authors:  Antoine Hommais; Julie Rayes; Anne Houllier; Bernadette Obert; Paulette Legendre; Agnes Veyradier; Jean-Pierre Girma; Anne-Sophie Ribba
Journal:  Thromb Haemost       Date:  2007-09       Impact factor: 5.249

10.  Crystal structure of the TSP-1 type 1 repeats: a novel layered fold and its biological implication.

Authors:  Kemin Tan; Mark Duquette; Jin-huan Liu; Yicheng Dong; Rongguang Zhang; Andrzej Joachimiak; Jack Lawler; Jia-huai Wang
Journal:  J Cell Biol       Date:  2002-10-21       Impact factor: 10.539

View more
  8 in total

Review 1.  Inherited thrombotic thrombocytopenic purpura.

Authors:  Miriam Galbusera; Marina Noris; Giuseppe Remuzzi
Journal:  Haematologica       Date:  2009-02       Impact factor: 9.941

2.  Two novel heterozygote missense mutations of the ADAMTS13 gene in a child with recurrent thrombotic thrombocytopenic purpura.

Authors:  Raffaella Rossio; Barbara Ferrari; Andrea Cairo; Ilaria Mancini; Giovanni Pisapia; Giulia Palazzo; Flora Peyvandi
Journal:  Blood Transfus       Date:  2012-09-12       Impact factor: 3.443

Review 3.  Pathophysiology of thrombotic thrombocytopenic purpura.

Authors:  Han-Mou Tsai
Journal:  Int J Hematol       Date:  2010-01       Impact factor: 2.490

4.  Amino acid residues Arg(659), Arg(660), and Tyr(661) in the spacer domain of ADAMTS13 are critical for cleavage of von Willebrand factor.

Authors:  Sheng-Yu Jin; Christopher G Skipwith; X Long Zheng
Journal:  Blood       Date:  2010-01-14       Impact factor: 22.113

5.  ADAMTS13 Secretion and Residual Activity among Patients with Congenital Thrombotic Thrombocytopenic Purpura with and without Renal Impairment.

Authors:  Erica Rurali; Federica Banterla; Roberta Donadelli; Elena Bresin; Miriam Galbusera; Sara Gastoldi; Flora Peyvandi; Mary Underwood; Giuseppe Remuzzi; Marina Noris
Journal:  Clin J Am Soc Nephrol       Date:  2015-09-04       Impact factor: 8.237

6.  Residual plasmatic activity of ADAMTS13 is correlated with phenotype severity in congenital thrombotic thrombocytopenic purpura.

Authors:  Luca A Lotta; Haifeng M Wu; Ian J Mackie; Marina Noris; Agnes Veyradier; Marie A Scully; Giuseppe Remuzzi; Paul Coppo; Ri Liesner; Roberta Donadelli; Chantal Loirat; Richard A Gibbs; April Horne; Shangbin Yang; Isabella Garagiola; Khaled M Musallam; Flora Peyvandi
Journal:  Blood       Date:  2012-04-23       Impact factor: 22.113

7.  Morbidities and mortality in patients with hereditary thrombotic thrombocytopenic purpura.

Authors:  Azra Borogovac; Jessica A Reese; Samiksha Gupta; James N George
Journal:  Blood Adv       Date:  2022-02-08

Review 8.  Proteolytic processing of von Willebrand factor by adamts13 and leukocyte proteases.

Authors:  Stefano Lancellotti; Maria Basso; Raimondo De Cristofaro
Journal:  Mediterr J Hematol Infect Dis       Date:  2013-09-02       Impact factor: 2.576

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.